Hilvel Ingredients and Usage

The active ingredients are Sofosbuvir (a nucleotide analog NS5B polymerase inhibitor) and Velpatasvir (an NS5A inhibitor). One tablet is taken once daily with or without food for 12 weeks, providing a complete treatment course for most Hepatitis C patients.

Hilvel is clinically indicated for:

• Chronic Hepatitis C virus (HCV) infection in adults
• All HCV genotypes (1, 2, 3, 4, 5, and 6)
• Patients with compensated cirrhosis
• Treatment-naïve and treatment-experienced patients
• HIV-HCV co-infected patients

How Does Hilvel Work?

Hilvel provides comprehensive antiviral action through dual mechanism:

1. NS5B Polymerase Inhibition: Sofosbuvir halts viral replication by acting as a chain terminator
2. NS5A Protein Inhibition: Velpatasvir blocks viral assembly and secretion
3. Pan-genotypic Coverage: Effective against all hepatitis C genotypes
4. High Barrier to Resistance: Minimal chance of viral resistance development

Hilvel Side Effects and Warnings

Common side effects include headache, fatigue, nausea, asthenia, and insomnia. Most side effects are mild to moderate in severity.

Serious Considerations

1. Hepatitis B Reactivation: Risk of HBV reactivation in co-infected patients – test for HBV before starting
2. Bradycardia with Amiodarone: Serious symptomatic bradycardia may occur with concomitant amiodarone
3. Drug Interactions: Significant interactions with rifampin, carbamazepine, and St. John’s wort
4. Renal Impairment: Safety not established in severe renal impairment
5. Pregnancy: Use only if potential benefit justifies potential risk

Hilvel Storage Conditions

Hilvel Tablets require proper storage conditions:

• Store below 30°C in original container
• Keep the bottle tightly closed
• Protect from moisture
• Keep out of reach of children
• Do not use after expiration date